Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher Bowman

Nurse Practitioner, Gerontology Fort Wayne, IN Nurse Practitioner

NPI 1841713229 CMS profile 11212191

7910 W Jefferson Blvd Ste 102, Fort Wayne, IN 46804

Open in the dashboard

General payments

$3,980

46 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Bowman of Fort Wayne, IN is reported in the CMS Open Payments database as having received $3,980 across 46 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $787 13
2024 General $381 6
2023 General $1,877 14
2022 General $450 8
2021 General $485 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Bowman
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Christopher Bowman were reported at $787. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Christopher Bowman Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $485 $133 $44–$396 $132
2022 $450 $142 $48–$452 $149
2023 $1,877 $158 $53–$482 $160
2024 $381 $171 $55–$533 $164
2025 $787 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $2,210 13 payments
  2. Maquet Cardiovascular U.S. Sales, L.L.C. $824 13 payments
  3. Atricure, Inc. $381 4 payments
  4. Abbott Laboratories $231 4 payments
  5. Ethicon US, LLC $192 7 payments
  6. Aroa Biosurgery Incorporated $46 2 payments
  7. Abiomed $36 1 payment
  8. Smith+Nephew, Inc. $32 1 payment
  9. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,904 37 payments
  2. Travel and Lodging $1,863 7 payments
  3. Education $212 2 payments
Products named General payments · program years 2021–2025
  1. STRATAFIX $1,917 11 payments
  2. VASOVIEW HEMOPRO 2 Cardiovascular Care $499 4 payments
  3. Vasoview Hemopro 2 Cardiology/Vascular Diseases $307 8 payments
  4. ATRICLIP LAA EXCLUSION SYSTEM $254 2 payments
  5. DERMABOND $212 2 payments
  6. CardioMEMS HF System $158 1 payment
  7. AtriCure cryoICE cryoSPHERE Cryoablation System $127 2 payments
  8. Echelon Flex $116 2 payments
  9. ETHICON $114 1 payment
  10. SYNERGY ABLATION SYSTEM $93 1 payment
  11. Other $425 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

248

Median for Nurse Practitioner: 389

Drug cost

$989

Median for Nurse Practitioner: $21,885

Branded share of claims

40.7%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 65 $378
Clopidogrel Clopidogrel Bisulfate Brand 36 $170
Atorvastatin Calcium Generic 29 $116
Potassium Chloride Generic 25 $96
Metoprolol Tartrate Generic 41 $81
Amiodarone Hcl Generic 14 $75
Carvedilol Generic 12 $36
Furosemide Generic 26 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$5,193

Medicare's payments for the services billed

Medicare patients

34

Average age 69

Services billed

72

13 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 68%
Diabetes 47%
Arthritis 47%
COPD 44%
Atrial fibrillation 41%
Cancer 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

46 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record